A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

Although efficacious vaccines have significantly reduced the morbidity and mortality of COVID-19, there remains an unmet medical need for treatment options, which monoclonal antibodies (mAbs) can potentially fill. This unmet need is exacerbated by the emergence and spread of SARS-CoV-2 variants of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hingankar, Nitin, Deshpande, Suprit, Das, Payel, Rizvi, Zaigham Abbas, Wibmer, Constantinos Kurt, Mashilo, Poppy, Ansari, Mohammed Yousuf, Burns, Alison, Barman, Shawn, Zhao, Fangzhu, Mukherjee, Sohini, Torres, Jonathan L., Chattopadhyay, Souvick, Mehdi, Farha, Sutar, Jyoti, Rathore, Deepak Kumar, Pargai, Kamal, Singh, Janmejay, Sonar, Sudipta, Jakhar, Kamini, Dandotiya, Jyotsna, Bhattacharyya, Sankar, Mani, Shailendra, Samal, Sweety, Singh, Savita, Kshetrapal, Pallavi, Thiruvengadam, Ramachandran, Batra, Gaurav, Medigeshi, Guruprasad, Ward, Andrew B., Bhatnagar, Shinjini, Awasthi, Amit, Sok, Devin, Bhattacharya, Jayanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089897/
https://www.ncbi.nlm.nih.gov/pubmed/35482816
http://dx.doi.org/10.1371/journal.ppat.1010465

Ejemplares similares

Ejemplares similares